About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Research News » ADHD Treatment -Phase 3 data on Lisdexamfetamine dimesylate Presented

ADHD Treatment -Phase 3 data on Lisdexamfetamine dimesylate Presented

The investigational ADHD treatment, lisdexamfetamine dimesylate (also known as NRP104 or LDX) by Shire plc and its collaborative partner New River Pharmacuticals has yielded a good

The investigational ADHD treatment, lisdexamfetamine dimesylate (also known as NRP104 or LDX) by Shire plc and its collaborative partner New River Pharmacuticals has yielded a good response in children with Attention Deficit Hyperactivity Disorder, it was announced today.

The data was presented at a national meeting of child and adolescent psychiatrists last weekend.

The study was done on 269 children between 6 and 12 who were treated for six months in an open label phase III study. A 60% improvement has been recorded in the primary ratings scale scores for ADHD symptoms, so the potential for LDX to be used effectively in ADHD has been recognised.

New River Pharmaceuticals formulated LDX as a new medication for ADHD which will act all day till 6 p.m.

The final results of the study are expected by mid 2007 when assessment of the children treated with LDX over a one year period will be completed.

Source-Eurekalert
MAL

Recommended Readings

Iodine Deficiency Disorder

Iodine Deficiency Disorder

To control IDD, the ‘National Goiter Control Program (NGCP)’ was launched which was later renamed as the ‘National Iodine Deficiency Disorder Control Program (NIDDCP)’.

Dysgraphia / Disorder of Written Expression / Writing Disorder

Dysgraphia / Disorder of Written Expression / Writing Disorder

Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor writing skills. It may occur alone or along with other disabilities such as speech problems and attention deficit disorder.

Dyslexia

Dyslexia is a reading disability that occurs when the brain does not properly recognize and process certain symbols.

Diet to control Attention Deficit Hyperactivity Disorder

Diet to control Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (ADHD) is a neurological disorder that affects children of school going age and often subsides as the child matures.

Sensory Processing Disorder (SPD)

Sensory Processing Disorder (SPD)

Sensory processing disorder / SPD is a brain disorder that interferes with the ability to process sensory information. The disorder poses day-to-day challenges, and therefore, early intervention is ideal for prevention.

Adult Attention-Deficit Hyperactivity Disorder (ADHD)

Adult Attention-Deficit Hyperactivity Disorder (ADHD)

Adult attention-deficit hyperactive disorder (ADHD) is a mental health condition in adults seen as hyperactivity, impulsiveness and reduced attention. ADHD impairs social, academic, neuropsychological and occupational behavior.

Latest Research News

Defibrillation Devices Turn Out to Be Both Life-Saving and Power-Saving

Defibrillation Devices Turn Out to Be Both Life-Saving and Power-Saving

New Defibrillators: Saving Lives, Saving Power! By using 1,000 times less electricity, these devices can save lives, alleviate pain, and minimize tissue damage.

WHO Flags 17 Disease-Causing Pathogens for Urgent Vaccine Development

WHO Flags 17 Disease-Causing Pathogens for Urgent Vaccine Development

The WHO has identified 17 disease-causing pathogens that urgently need vaccines, aiming to prevent outbreaks and strengthen global health response efforts.

Memorial Tattoos: Expressions of Grief and Identity

Memorial Tattoos: Expressions of Grief and Identity

A study explores the rise of memorial tattoos in Israel post-Hamas attacks, reflecting collective grief, identity, and coping with trauma through art.

Personality Profiles Linked to Physical Activity and Health in Older Adults

Personality Profiles Linked to Physical Activity and Health in Older Adults

A study by the University of Jyväskylä found that personality profiles impact physical activity and sedentary behavior patterns, which could influence long-term health outcomes.

10 Million Eyes at Risk: Glaucoma's Looming Threat

10 Million Eyes at Risk: Glaucoma's Looming Threat

Diagnosed primary open-angle glaucoma cases are set to reach 10M by 2033 in 7 major markets, driven by aging populations, greater awareness, and improved diagnosis.

Advertisement